Subgroup identification based on differential effect search-A recursive partitioning method for establishing response to treatment in patient subpopulations

Design and Analysis Considerations in Clinical Trials With a Sensitive Subpopulation

(2010) Yan D. Zhao et al.   Statistics in Biopharmaceutical Research

The Use of a Clinical Utility Index to Compare Insomnia Compounds: A Quantitative Basis for Benefit–Risk Assessment

(2008) D Ouellet et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Interaction Trees with Censored Survival Data

(2008) Xiaogang Su et al.  

Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer

(2008) Giorgio Vittorio Scagliotti et al.   JOURNAL OF CLINICAL ONCOLOGY

Wild-TypeKRASIs Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer

(2008) Rafael G. Amado et al.   JOURNAL OF CLINICAL ONCOLOGY

K-rasMutations and Benefit from Cetuximab in Advanced Colorectal Cancer

(2008) Christos S. Karapetis et al.   NEW ENGLAND JOURNAL OF MEDICINE

A flexible strategy for testing subgroups and overall population

(2008) Mohamed Alosh et al.   STATISTICS IN MEDICINE

Adaptive designs for selecting drug combinations based on efficacy–toxicity response

(2007) Vladimir Dragalin et al.   JOURNAL OF STATISTICAL PLANNING AND INFERENCE